August 14th 2025, 3:00pm
Real-world data show that Enhertu benefits those with HR+ breast cancer, whereas Trodelvy is effective as an initial treatment for HER2-null/HER2– disease.
August 14th 2025, 1:00pm
There are many reliable resources available to patients with kidney cancer, as well as their families and caregivers.
August 13th 2025, 9:00pm
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
August 13th 2025, 8:00pm
Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and aided in remission.
August 13th 2025, 7:00pm
Among patients with advanced gastrointestinal stromal tumors, Gleevec and Mektovi was associated with benefits in progression and survival.
August 13th 2025, 5:00pm
When I was diagnosed with peritoneal mesothelioma at 21 years old, the doctors gave me 18 months to live; that was 18 years ago.
August 13th 2025, 4:00pm
About one in six men with grade group 1 prostate cancer have higher-risk disease, showing outcomes vary and biopsy grade may underestimate risk.
August 13th 2025, 3:00pm
Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.
August 13th 2025, 1:00pm
Dr. Aaron Gerds explained when treatment with rusfertide will become accessible for patients with a myeloproliferative neoplasm like polycythemia vera.
August 12th 2025, 9:00pm
I’m a testicular cancer survivor diagnosed at 20. My story is about finding strength, building routines, and sharing hope for those facing cancer.
Top Lung Cancer Stories from October: Insights, and Patient Journeys
How AI Can Put Patients at the Center of Cancer Care
FDA Approves Darzalex Faspro in High-Risk Smoldering Multiple Myeloma
Sharing More Than 25 Years of Brain Tumor Survival